Different studies have described dysregulated MAGP-1 levels in diverse cancers underlining its implication in tumour progression, particularly in the processes of epithelial mesenchymal transition (EMT) due to its interaction with TGF-β [27]. This evidence concerns the gene TGFB1 and cancer.